Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus enalapril in chronic heart failure
NL-OMON39821Phase 3Active, not recruiting
- Sponsor
- Novartis
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aliskiren and enalapril in chronic heart failure (CHF), sponsored by Novartis. Started Jul 2009; status: active, not recruiting.
02
Drugs
aliskirenenalapril
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NL-OMON39821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39821.